Prospective study confirms that bronchiolitis in early infancy increases the risk of reduced lung function at 10-13 years of age.


Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
01 2019
Historique:
received: 07 01 2018
revised: 09 03 2018
accepted: 16 05 2018
pubmed: 22 5 2018
medline: 31 3 2020
entrez: 22 5 2018
Statut: ppublish

Résumé

This study evaluated children hospitalised for bronchiolitis at less than six months of age to see if they had reduced lung function in early adolescence. We have prospectively followed 166 children hospitalised for infant bronchiolitis in 2001-2004 at Tampere University Hospital, Finland. At 10-13 years of age, flow-volume spirometry was measured in 89 cases and 108 controls without infant bronchiolitis from the local population register. Parameters of flow-volume spirometry before and after bronchodilation were analysed. Forced expiratory volume in one second/forced vital capacity (FEV1/FVC) after bronchodilation was lower in cases than controls. FEV1 was pathological - under the 5th percentile of the national references - in 25% of cases and 12% of controls (p = 0.020) before bronchodilation and in 18% of cases and 5% of controls (p = 0.003) after bronchodilation. FEV1/FVC was pathological in 25% of cases and 13% of controls (p = 0.034) before bronchodilation. Logistic regression, adjusted for current asthma and maternal smoking, showed that infant bronchiolitis was associated with pathological FEV1 before (odds ratio 2.4) and after (odds ratio 4.4) bronchodilation. The result was similar for positive respiratory syncytial virus cases. Reduced FEV1 after bronchodilation was found in early adolescence after infant bronchiolitis, suggesting irreversible bronchial obstruction.

Identifiants

pubmed: 29782663
doi: 10.1111/apa.14412
doi:

Substances chimiques

Adrenal Cortex Hormones 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

124-130

Subventions

Organisme : Tampere Tuberculosis Foundation and the Paediatric Research Foundation of Finland
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2018 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Auteurs

Riikka Riikonen (R)

Center for Child Health Research, Tampere University and University Hospital, Tampere, Finland.

Eero Lauhkonen (E)

Center for Child Health Research, Tampere University and University Hospital, Tampere, Finland.

Sari Törmänen (S)

Center for Child Health Research, Tampere University and University Hospital, Tampere, Finland.

Katri Backman (K)

Department of Paediatrics, Kuopio University Hospital, Kuopio, Finland.

Petri Koponen (P)

Center for Child Health Research, Tampere University and University Hospital, Tampere, Finland.

Merja Helminen (M)

Department of Paediatrics, Tampere University Hospital, Tampere, Finland.

Kirsi Nuolivirta (K)

Department of Paediatrics, Seinäjoki Central Hospital, Seinäjoki, Finland.

Matti Korppi (M)

Center for Child Health Research, Tampere University and University Hospital, Tampere, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH